A new form of medication that can help relieve symptoms of mental health issues is now available to people with schizophrenia and bipolar disorder, and could eventually replace the medication used to treat the conditions.
New form of anti-psychotic medication can help alleviate symptoms of schizophrenia and mood disordersThe medication is called pku treatment, and it has been approved by the Australian Health Practitioner Regulation Agency (AHPRA) to treat schizophrenia and major depressive disorder.
The medication can be prescribed under the Mental Health Treatment Act 2017.
The new form is being developed by New Zealand-based firm, BioMedi.
BioMedi, which was founded in 2014, was awarded the New Zealand Mental Health and Substance Abuse Therapy Award in June 2017.
It has since grown into a global pharmaceutical company with more than 80 employees, and has developed more than 30 products.
The company has also partnered with the Australian Government to develop a pilot program to use the medication.
The medication works by targeting the neurotransmitter dopamine, and by reducing the level of serotonin in the brain, the medication can improve mood and anxiety.
The treatment can also help with memory loss, which is caused by a decrease in serotonin, or dementia, which has caused loss of memory and cognitive function.
The drug also has the ability to treat depression.
The drug can be used to help treat severe mental health disorders like schizophrenia, bipolar disorder and depressionThe new medication can have a range of different applications, including as an alternative to medications used to manage depression, anxiety and depression.
Currently, pku therapy can be taken by people aged from 16 to 45.
The New Zealand Medicines and Healthcare Products Regulatory Agency (MHPGRA) is responsible for regulating the use of medicines and products.
The AHPRA has approved the new medication, which should be available to patients by the end of 2018.
It’s important to note that the medication is not approved by any Australian State Government and is not covered by Medicare.
A new form or type of medication for people who have mental health problemsThe new pku medication is being created by BioMedí and the AHPMA.
The Australian Government is supporting the development of the medication, and will also be working with BioMedicines team to develop an application for the drug.
It will be made available to Medicare through the new pak.
Topics:health,mental-health,diseases-and-disorders,psychosis,australiaFirst posted November 19, 2018 09:37:46Contact Sam Newman